orforglipron vs retatrutide & Review: Benefits, Side Effects & More Orforglipron vs tirzepatide | NiceRx

Clinical assessments were conducted every 3 months to evaluate efficacy, measured as percentage of total weight loss (%TWL), excess weight loss (%EWL), changes in BMI, and improvement in comorbidities, as well as tolerance, monitored for adverse effects including gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea) and discontinuation rates

The results at 48 weeks told a striking story

Some GLP-1 users report low energy from eating less, while others find they have fewer crashes, perhaps because of better blood sugar regulation

Excessive weight loss may occur too quickly, requiring dose adjustments

Some people notice mild changes in hunger patterns within 24-72 hours of the first injection